We are live on ! Find out more
JC

Jacobs & Co Portfolio holdings

AUM $1.17B
1-Year Est. Return 37.3%
This Fund
S&P 500
This Quarter Est. Return
+6.36%
1 Year Est. Return
+37.3%
3 Year Est. Return
+92.23%
5 Year Est. Return
+114.23%
10 Year Est. Return
+410.55%
AUM
$553M
AUM Growth
+$21.4M
Cap. Flow
-$13.5M
Cap. Flow %
-2.43%
Top 10 Hldgs %
23.35%
Holding
124
New
1
Increased
20
Reduced
85
Closed
2

Top Buys

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$330K
2
CVGW
Calavo Growers
CVGW
+$265K
3
LH icon
Labcorp
LH
+$226K
4
BUD icon
AB InBev
BUD
+$181K
5
SLB icon
SLB Ltd
SLB
+$180K

Top Sells

Rank Stock Value
1
REGN icon
Regeneron Pharmaceuticals
REGN
+$1.58M
2
GE icon
GE Aerospace
GE
+$1.54M
3
BA icon
Boeing
BA
+$1.17M
4
META icon
Meta Platforms (Facebook)
META
+$865K
5
AAPL icon
Apple
AAPL
+$783K

Sector Composition

Rank Sector Weight
1 Technology 16.48%
2 Healthcare 15.63%
3 Industrials 12.54%
4 Communication Services 12.1%
5 Consumer Staples 11.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WTS icon
76
Watts Water Technologies
WTS
$11.5B
$1.74M 0.31%
22,900
-655
-3% -$46.7K
KDP icon
77
Keurig Dr Pepper
KDP
$42.3B
$1.58M 0.29%
16,320
-225
-1% -$20.2K
PCAR icon
78
PACCAR
PCAR
$69.8B
$1.56M 0.28%
33,045
– –
QCOM icon
79
Qualcomm
QCOM
$155B
$1.55M 0.28%
8,272
-65
-0.8% -$3.94K
YUMC icon
80
Yum China
YUMC
$16.5B
$1.41M 0.25%
35,215
-910
-3% -$37.4K
DD icon
81
DuPont de Nemours
DD
$18.5B
$1.38M 0.25%
7,629
-87
-1% -$15.7K
COP icon
82
ConocoPhillips
COP
$147B
$1.12M 0.2%
20,431
-2,590
-11% -$133K
TGT icon
83
Target
TGT
$65.6B
$1.07M 0.19%
16,413
-100
-0.6% -$6.04K
ORCL icon
84
Oracle
ORCL
$374B
$1.05M 0.19%
22,144
-785
-3% -$38.5K
REGN icon
85
Regeneron Pharmaceuticals
REGN
$78.5B
$996K 0.18%
31,557
-3,900
-11% -$1.58M
CL icon
86
Colgate-Palmolive
CL
$73.1B
$883K 0.16%
11,712
– –
UNFI icon
87
United Natural Foods
UNFI
$3.08B
$748K 0.14%
15,185
-1,219
-7% -$53.3K
WFC icon
88
Wells Fargo
WFC
$261B
$746K 0.13%
12,300
-480
-4% -$27.1K
SNY icon
89
Sanofi
SNY
$103B
$696K 0.13%
16,200
-25
-0.2% -$1.15K
BP icon
90
BP
BP
$116B
$675K 0.12%
17,551
-1,306
-7% -$47.3K
VIAB
91
DELISTED
Viacom Inc. Class B
VIAB
$624K 0.11%
20,278
-15,110
-43% -$410K
TWX
92
DELISTED
Time Warner Inc
TWX
$546K 0.1%
5,980
+142
+2% +$13.4K
WMT icon
93
Walmart Inc
WMT
$885B
$496K 0.09%
15,075
– –
PM icon
94
Philip Morris
PM
$297B
$449K 0.08%
4,250
– –
BAC icon
95
Bank of America
BAC
$435B
$416K 0.08%
14,124
-100
-0.7% -$2.76K
PSX icon
96
Phillips 66
PSX
$84.9B
$396K 0.07%
3,918
-150
-4% -$14.3K
TWTR
97
DELISTED
Twitter, Inc.
TWTR
$388K 0.07%
16,181
-464
-3% -$9.53K
MPC icon
98
Marathon Petroleum
MPC
$92.4B
$376K 0.07%
5,700
-400
-7% -$24.5K
HPQ icon
99
HP
HPQ
$24.9B
$355K 0.06%
16,900
-500
-3% -$10.6K
SNA icon
100
Snap-on
SNA
$21.2B
$321K 0.06%
4,984
+880
+21% +$142K
1 2 3
4
5

Similar funds

OCAI
O'Connor Alternative Investments New York $1.17B AUM
BONST
Bank of Nova Scotia Trust Toronto, Ontario, Canada $1.16B AUM 27.04% 1-Year Est. Return
AMI
Amica Mutual Insurance Providence, Rhode Island $1.16B AUM 21.34% 1-Year Est. Return
GAB
German American Bancorp Jasper, Indiana $1.16B AUM 25.7% 1-Year Est. Return
SCP
Sandhill Capital Partners Buffalo, New York $1.16B AUM 12.37% 1-Year Est. Return
FG
Fiduciary Group Savannah, Georgia $1.17B AUM 16.92% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jacobs & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Jacobs & Co held 124 positions worth $553M, up 4% from $532M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Trading was light in Q4 2017: portfolio turnover was 2.4%. Jacobs & Co opened 1 new position and exited 2, leaving the 124-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Healthcare and Industrials.

  • Jacobs & Co's largest Q4 2017 buy was Calavo Growers: 3,598 shares worth $303K.
  • Jacobs & Co added most to Celgene Corp in Q4 2017, an estimated $330K increase.
  • Jacobs & Co's biggest Q4 2017 reduction was Regeneron Pharmaceuticals, cutting an estimated $1.58M.
  • Jacobs & Co fully exited PG&E in Q4 2017, selling an estimated $347K.
  • Jacobs & Co's ten largest holdings make up 23% of its $553M portfolio in Q4 2017.
  • Jacobs & Co opened 1 new position and closed 2 in Q4 2017.
  • Jacobs & Co's portfolio value rose 4% quarter-over-quarter to $553M.

Based on Jacobs & Co's 13F filing for Q4 2017, filed 9 Feb 2018.